Tofacitinib Ointment For Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT01831466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Study identification
- NCT ID
- NCT01831466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 476 participants
Conditions and interventions
Conditions
Interventions
- tofacitinib ointment 20 mg/g Drug
- tofacitinib ointment 10 mg/g Drug
- placebo ointment (vehicle) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013
- Primary completion
- Aug 31, 2014
- Completion
- Aug 31, 2014
- Last update posted
- Nov 24, 2015
2013 – 2014
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Bakersfield Dermatology and Skin Cancer Medical Center | Bakersfield | California | 93304 | — |
| UC Irvine Dermatology Research | Irvine | California | 92697 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Park Avenue Dermatology, PA | Orange Park | Florida | 32073 | — |
| Olympian Clinical Research | Tampa | Florida | 33609 | — |
| Atlanta Dermatology, Vein & Research Center | Alpharetta | Georgia | 30022 | — |
| Advanced Medical Research, Inc | Atlanta | Georgia | 30342 | — |
| MedaPhase Inc. | Newnan | Georgia | 30263 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS) | Boston | Massachusetts | 02114 | — |
| Michigan Center for Skin Care Research | Clinton Township | Michigan | 48038 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27104 | — |
| Radiant Research, Inc. | Cincinnati | Ohio | 45249 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research Center, PC | Portland | Oregon | 97223 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Dermatology Research Associates | Nashville | Tennessee | 37203 | — |
| Arlington Research Center Inc. | Arlington | Texas | 76011 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Menter Dermatology Research Institute | Dallas | Texas | 75246 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| Lee Medical Associates | San Antonio | Texas | 78229 | — |
| Progressive Clinical Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01831466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01831466 live on ClinicalTrials.gov.